- Home
- VRTX vs PBR Comparison
VRTX vs PBR Comparison
Compare VRTX & PBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRTX
- PBR
- Stock Information
- Founded
- VRTX 1989
- PBR 1953
- Country
- VRTX United States
- PBR Brazil
- Employees
- VRTX N/A
- PBR N/A
- Industry
- VRTX EDP Services
- PBR Oil & Gas Production
- Sector
- VRTX Technology
- PBR Energy
- Exchange
- VRTX Nasdaq
- PBR Nasdaq
- Market Cap
- VRTX 104.8B
- PBR 91.1B
- IPO Year
- VRTX 1991
- PBR N/A
- Fundamental
- Price
- VRTX $422.00
- PBR $13.72
- Analyst Decision
- VRTX Buy
- PBR Strong Buy
- Analyst Count
- VRTX 30
- PBR 8
- Target Price
- VRTX $503.92
- PBR $18.28
- AVG Volume (30 Days)
- VRTX 2.1M
- PBR 12.5M
- Earning Date
- VRTX 02-03-2025
- PBR 02-26-2025
- Dividend Yield
- VRTX N/A
- PBR 18.02%
- EPS Growth
- VRTX N/A
- PBR N/A
- EPS
- VRTX N/A
- PBR 1.20
- Revenue
- VRTX $10,625,800,000.00
- PBR $92,525,343,651.00
- Revenue This Year
- VRTX $12.56
- PBR $0.70
- Revenue Next Year
- VRTX $8.34
- PBR $1.66
- P/E Ratio
- VRTX N/A
- PBR $5.45
- Revenue Growth
- VRTX 10.06
- PBR N/A
- 52 Week Low
- VRTX $377.85
- PBR $12.55
- 52 Week High
- VRTX $519.88
- PBR $17.91
- Technical
- Relative Strength Index (RSI)
- VRTX 48.34
- PBR 54.82
- Support Level
- VRTX $397.25
- PBR $13.38
- Resistance Level
- VRTX $425.49
- PBR $13.74
- Average True Range (ATR)
- VRTX 8.24
- PBR 0.26
- MACD
- VRTX 3.71
- PBR 0.11
- Stochastic Oscillator
- VRTX 79.84
- PBR 85.40
About VRTX Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease. Additionally, Vertex is evaluating small-molecule inhibitors targeting acute and chronic pain using nonopioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
About PBR Petroleo Brasileiro S.A.- Petrobras
Petrobras is a Brazil-based integrated energy company controlled by the Brazilian government. The company focuses on exploration and production of oil and gas in Brazilian offshore fields. Production in 2023 was 2.8 million barrels of oil equivalent a day (80% oil production), and reserves stood at 10.9 billion boe (85% oil). At end-2023, Petrobras operated 10 refineries in Brazil with capacity of 1.8 million barrels a day and distributes refined products and natural gas throughout Brazil.